Novo Nordisk A/SNVONYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank7
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P7
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
3 yr
Consecutive declineDecelerating
PeriodValue
2025-1.54%
202411.07%
202338.06%
202243.43%
20215.87%
202011.05%
20194.85%
20188.38%
2017-14.79%
201626.19%